Serum Biomarkers for Predicting Liver Fibrosis in Hepatitis C
Author Information
Author(s): Valva Pamela, Casciato Paola, Diaz Carrasco Juan M., Gadano Adrian, Galdame Omar, Galoppo María Cristina, Mullen Eduardo, De Matteo Elena, Preciado María Victoria
Primary Institution: Ricardo Gutiérrez Children's Hospital, Buenos Aires, Argentina
Hypothesis
The study aims to determine specific serum markers that correlate with liver fibrosis progression during chronic HCV infection.
Conclusion
The study suggests that TIMP-1 is clinically useful for predicting liver fibrosis in pediatric HCV patients, while HA, PIIINP, and TGF-ß1 may be useful in adults.
Supporting Evidence
- 64% of children and 54% of adults had significant fibrosis.
- TIMP-1 was associated with advanced fibrosis in children.
- HA, PIIINP, and TGF-ß1 were associated with advanced fibrosis in adults.
- Biopsies could have been avoided in 72% of pediatric patients using TIMP-1.
- Biopsies could have been avoided in 87% of adult patients using HA.
Takeaway
Doctors can use blood tests to check for liver damage in kids and adults with hepatitis C instead of doing a painful liver biopsy.
Methodology
The study analyzed liver biopsies and serum samples from 22 pediatric and 22 adult HCV patients to evaluate serum markers related to liver fibrosis.
Potential Biases
Potential sampling error and understaging of fibrosis due to biopsy length and fragmentation.
Limitations
The study had a small sample size and did not include pediatric patients without liver fibrosis or adults with cirrhosis.
Participant Demographics
22 pediatric patients (8 male, 14 female; ages 1-17) and 22 adult patients (13 male, 9 female; ages 38-74).
Statistical Information
P-Value
p=0.011 for HA, p=0.016 for PIIINP, p=0.039 for TIMP-1, p=0.022 for TGF-ß1.
Confidence Interval
95% CI for AUROC values provided in the results.
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website